News•1 week ago
Drug developer City Therapeutics files for US IPO
City Therapeutics filed for a US initial public offering on Thursday, advancing the drug developer toward a public listing. Terms, share count, and pricing were not disclosed.
MarketLens
What is Seaport Therapeutics and Why is its IPO Significant
5 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•1 months ago
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO
Seaport Therapeutics went public with a prodrug platform, drawing board members from major neuroscience acquisitions. The IPO could attract acquirers like Bristol Myers and Johnson & Johnson, potentia...
Stock News•1 months ago
Inside Latigo Biotherapeutics' IPO: A Non-Opioid Pain Bet Goes Public
Latigo Biotherapeutics (NASDAQ:LTGO) went public with a strong reception, marking its debut as a non-opioid pain treatment developer. The IPO's success signals investor appetite for alternatives in th...
Breaking News
View All →Featured Articles
Top Headlines
Stock News•1 hour ago
Microsoft (MSFT) Exceeds Market Returns: Some Facts to Consider
Stock News•1 hour ago
Nvidia (NVDA) Outperforms Broader Market: What You Need to Know
Stock News•1 hour ago
Tesla (TSLA) Laps the Stock Market: Here's Why
Stock News•1 hour ago
If you'd bought $10,000 worth of Amazon stock 10 years ago, here's how much you'd have today
Stock News•1 hour ago